Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

This publication has 26 references indexed in Scilit:

• Use of Xpert^® MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan
  The International Journal of Tuberculosis and Lung Disease, 2016
• Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015
  The International Journal of Tuberculosis and Lung Disease, 2015
• Management of latentMycobacterium tuberculosisinfection: WHO guidelines for low tuberculosis burden countries
  European Respiratory Journal, 2015
• Systematic Review of Mutations in Pyrazinamidase Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis Clinical Isolates
  Antimicrobial Agents and Chemotherapy, 2015
• PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data
  Journal of Clinical Microbiology, 2015
• Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers
  The Journal of Infectious Diseases, 2015
• Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients
  The International Journal of Tuberculosis and Lung Disease, 2014
• Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
  European Respiratory Journal, 2011
• Size and Usage Patterns of Private TB Drug Markets in the High Burden Countries
  PLOS ONE, 2011
• Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
  Antimicrobial Agents and Chemotherapy, 2008